Project Oncology®

195 Epizód

1. Redefining Cancer Care with Functional Precision Medicine

   Közzétéve: 2025. 08. 14.
2. Optimizing Second-Line CAR T Decisions in R/R Large B-Cell Lymphoma

   Közzétéve: 2025. 08. 07.
3. Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies

   Közzétéve: 2025. 08. 06.
4. Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access

   Közzétéve: 2025. 08. 04.
5. Pediatric Sickle Cell Disease: Analyzing Trends in Medication Utilization

   Közzétéve: 2025. 07. 29.
6. Analyzing Toxicity Trends Post-CAR T-Cell Therapy: Implications for Patient Monitoring

   Közzétéve: 2025. 07. 23.
7. Sickle Cell Disease Care: Balancing Disease-Modifying and Curative Therapies

   Közzétéve: 2025. 07. 22.
8. Cardiac Complications in Sickle Cell Disease: Emerging Evidence and Risks

   Közzétéve: 2025. 07. 21.
9. Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access

   Közzétéve: 2025. 06. 23.
10. Subcutaneous Cancer Immunotherapy at Home: Transforming Trials and Patient Care

    Közzétéve: 2025. 06. 10.
11. Bringing Cancer Care Home: How Subcutaneous Immunotherapy Can Help Ease the Burden

    Közzétéve: 2025. 06. 05.
12. Unpacking the Logistics of At-Home Subcutaneous Cancer Immunotherapy Delivery

    Közzétéve: 2025. 06. 05.
13. Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study

    Közzétéve: 2025. 06. 03.
14. Trial in Progress: Phase 3 MoonRISe-3 Study

    Közzétéve: 2025. 05. 01.
15. First Results From Cohort 4 of the SunRISe-1 Trial

    Közzétéve: 2025. 05. 01.
16. HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)

    Közzétéve: 2025. 04. 15.
17. Targeting CD123 in AML: The Latest Therapeutic Advancements

    Közzétéve: 2025. 04. 11.
18. Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies

    Közzétéve: 2025. 04. 07.
19. Navigating a Positive MCED Test and Negative Diagnostic Workup: Real-World Data

    Közzétéve: 2025. 03. 28.
20. AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy

    Közzétéve: 2025. 03. 14.